< Back to situations

We’ll email you as it develops, and you can follow the whole thread from day one.

[SITUATION] · [ACTIVE]

2 clusters · 6 sources · 1 days · First seen · Last updated

Categories: BUSINESS

Royal Bank of Canada portfolio adjustments

Entities: Royal Bank of Canada · Readystate Asset Management LP · Braskem S.A. · Bank of America Corp. · Revolution Medicines Inc.

Overview

In the first quarter, Royal Bank of Canada disclosed a mixed set of equity moves. In an early filing, the bank added roughly 470,882 shares of Sanofi and 141,376 shares of Novo Nordisk, taking its holdings in the two European drugmakers to about 0.13 % and 0.10 % of outstanding stock respectively, with a combined value near US$318 million. Later the same day, a separate 13‑F filing showed RBC trimming other positions: it sold 18,314 Ferrari shares, reducing its stake to about 0.19 % (≈US$152 million), and cut its Boyd Group Services holding by 7.6%, leaving a 4.26 % stake worth roughly US$151 million. Together the filings illustrate RBC’s ongoing rebalancing of its investment portfolio, increasing exposure to the pharmaceutical sector while scaling back holdings in automotive and services firms.

Claims

What the coverage asserts, and how well corroborated each claim is across sources.

Timeline

  1. 2 days ago

    [BUSINESS] 6 sources
    Royal Bank of Canada Reduces Stakes in Ferrari and Boyd Group Services

    Royal Bank of Canada cut its Ferrari stake by 3.9% and its Boyd Group Services stake by 7.6% in Q1, reducing holdings to $151.7 M and $151.4 M respectively, per its latest 13F filing.

  2. 2 days ago

    [BUSINESS] 2 sources
    Royal Bank of Canada boosts stakes in Sanofi and Novo Nordisk

    Royal Bank of Canada raised its Sanofi stake to 3.16 M shares ($152 M) and its Novo Nordisk stake to 4.53 M shares ($166 M) in Q1, according to its latest SEC filing.

Sources

hospizdienst.de · mommygearest.com · paparazzi.com.ar · stocknews.com · stocktitan.net · teleborsa.it